Wed, April 10, 2024

Luke Sergott Maintained (TXG) at Buy with Decreased Target to $45 on, Apr 10th, 2024

Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $55 to $45 on, Apr 10th, 2024.

Luke has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derik De Bruin of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $54 on, Tuesday, December 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Luke


  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $63 on, Friday, February 16th, 2024
  • Subbu Nambi of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Thursday, December 14th, 2023
  • Doug Schenkel of "Wolfe Research" Initiated at Buy on, Wednesday, December 13th, 2023